Latest Sonire Therapeutics News & Updates

See the latest news and media coverage for Sonire. We track all announcements, press releases, and industry mentions in real time, all in one place.

Sonire Therapeutics (Sonire)

Medical device developer for ultrasound-guided cancer treatment

sonire-therapeutics.com

Headquarters: Tokyo, Japan
Founded year: 2020
Company type: Private company
Number of employees: 10–50
Industry: Advanced Medical Equipment & Technology

Last updated September 8

Latest news about Sonire Therapeutics (Sonire)

In short: Sonire secured $31m in funding, launched US HIFU pancreatic cancer trials, and earned FDA Breakthrough Device designation.

Company announcements

September 8 Sonire

Sonire Introduces HIFU Pancreatic Cancer Treatment Platform

The platform uses therapeutic and monitoring ultrasound for precise, localized treatment without anesthesia, preserving healthy tissue in complex pancreatic areas.

June 17 Sonire

Sonire receives 2 billion yen subsidy from NEDO to develop HIFU treatment device

To accelerate the global commercialization of pancreatic cancer treatment devices, it will receive financial support from the National Research and Development Agency for New Energy and Industrial Technology Development Organization.

June 1 Sonire

Sonire completes SUNRISE-I trial enrollment

The pancreatic cancer study moves to safety and efficacy data generation for ultrasound-guided HIFU therapy.

May 7 Sonire

Sonire begins US clinical trial for pancreatic cancer HIFU

We will launch the first US clinical study, SUNRISE-II, using the next-generation device Suizenji and advance its development.

Media coverage

June 17 Morningstar

Sonire Therapeutics Awarded $13 Million Through NEDO Deep-Tech Startups Support Program (DTSU) to Advance Global Commercialization of Pancreatic Cancer Treatment

PALO ALTO, Calif., June 17, 2026 /PRNewswire/ -- Sonire Therapeutics, a U.S.-based clinical-stage medical device company pioneering non-invasive ultrasound therapies for cancer treatment, today ...

June 17 Yahoo Finance

Sonire Therapeutics awarded $13m from Japanese government-backed innovation agency

The funds for Sonire Therapeutics KK, which is headquartered in Tokyo, Japan but also has a presence in the US, originate from the New Energy...

April 15 Yahoo Finance

Sonire Therapeutics Closes $18 Million Series A Financing to Advance Breakthrough HIFU Therapy for Pancreatic Cancer, Expands U.S. Clinical Development

PALO ALTO, Calif., April 15, 2026 /PRNewswire/ -- Sonire Therapeutics, a U.S. based clinical-stage medical device company, today announced $18M in Series A financing. The...

October 16, 2024 MarketWatch

SONIRE's HIFU Therapy System Designated as Breakthrough Device by FDA

TOKYO, Oct. 16, 2024 /PRNewswire/ -- SONIRE Therapeutics Inc. (hereinafter referred to as "SONIRE"), based in Tokyo, Japan, announces that its self-developed next-generation HIFU (High-Intensity...

Never miss news about Sonire

Track Sonire and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.